Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 25.05 is 115% above its 5-year average of 11.68, near the high end of its 5-year range (5.68–25.05).
As of the fiscal period ended Tuesday, June 30, 2026. 125.69% above its 12-month average of 11.10.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 25.05.
CURRENT RATIO
25.05
CURRENT RATIO AVG TTM
11.10
CURRENT RATIO AVG 3Y
10.02
CURRENT RATIO AVG 5Y
11.68
CURRENT RATIO AVG 10Y
13.01
CURRENT RATIO AVG 15Y
15.34
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+125.69%
CURRENT VS 3Y AVG
+150.00%
CURRENT VS 5Y AVG
+114.53%
CURRENT VS 10Y AVG
+92.50%
CURRENT VS 15Y AVG
+63.34%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+566.18%
vs the sector median at left
Prothena Corporation plc
Market Cap
$419.87M
Current Ratio
25.05
TTM Avg
11.10
3Y Avg
10.02
5Y Avg
11.68
Market Cap
$422.86M
Current Ratio
22.29
TTM Avg
19.64
3Y Avg
11.19
5Y Avg
11.30
Market Cap
$416.27M
Current Ratio
6.74
TTM Avg
3.59
3Y Avg
4.96
5Y Avg
4.92
Market Cap
$426.51M
Current Ratio
3.48
TTM Avg
10.77
3Y Avg
42.35
5Y Avg
30.00
Market Cap
$411.21M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $419.87M | 25.05 | 11.10 | 10.02 | 11.68 |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | 3.19 | 3.65 | 4.66 | 6.11 |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 2.21 | 2.33 | 2.18 | 2.30 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | 22.29 | 19.64 | 11.19 | 11.30 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 6.74 | 3.59 | 4.96 | 4.92 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 9.44 | 11.90 | 14.34 | 23.42 |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 3.60 | 3.12 | 4.79 | 5.52 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 3.48 | 10.77 | 42.35 | 30.00 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 16.52 | 13.61 | 8.86 | 8.86 |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 2.64 | 6.72 | 6.86 | 10.11 |
Current Ratio
25.05
Quick Ratio
25.05
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 25.05 |
| 2026-03-31 | 10.43 |
| 2025-12-31 | 7.72 |
| 2025-09-30 | 6.61 |
| 2025-06-30 | 5.68 |
| 2025-03-31 | 9.00 |
| 2024-12-31 | 10.01 |
| 2024-09-30 | 11.52 |
| 2024-06-30 | 12.54 |
| 2024-03-31 | 13.08 |
| 2023-12-31 | 11.24 |
| 2023-09-30 | 12.94 |
| 2023-06-30 | 9.46 |
| 2023-03-31 | 14.33 |
| 2022-12-31 | 14.34 |
| 2022-09-30 | 10.37 |
| 2022-06-30 | 13.00 |
| 2022-03-31 | 15.22 |
| 2021-12-31 | 17.48 |
| 2021-09-30 | 20.81 |
| 2021-06-30 | 7.74 |
| 2021-03-31 | 15.02 |
| 2020-12-31 | 11.58 |
| 2020-09-30 | 14.75 |
| 2020-06-30 | 18.40 |
| 2020-03-31 | 21.05 |
| 2019-12-31 | 21.36 |
| 2019-09-30 | 12.88 |
| 2019-06-30 | 14.95 |
| 2019-03-31 | 27.85 |
| 2018-12-31 | 28.90 |
| 2018-09-30 | 19.34 |
| 2018-06-30 | 10.71 |
| 2018-03-31 | 15.11 |
| 2017-12-31 | 11.41 |
| 2017-09-30 | 11.95 |
| 2017-06-30 | 12.92 |
| 2017-03-31 | 15.27 |
| 2016-12-31 | 9.53 |
| 2016-09-30 | 11.26 |
| 2016-06-30 | 13.47 |
| 2016-03-31 | 20.75 |
| 2015-12-31 | 16.99 |
| 2015-09-30 | 21.21 |
| 2015-06-30 | 30.19 |
| 2015-03-31 | 29.80 |
| 2014-12-31 | 24.86 |
| 2014-09-30 | 30.97 |
| 2014-06-30 | 27.14 |
| 2014-03-31 | 22.27 |
| 2013-12-31 | 24.06 |
| 2013-09-30 | 13.34 |
| 2013-06-30 | 12.51 |
| 2013-03-31 | 23.75 |
| 2012-12-31 | 72.16 |
| 2012-09-30 | 0.02 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.00 |
